The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801
Research output: Contribution to journal › Article › peer-review
143Scopus
citations
Fingerprint
Dive into the research topics of 'The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801'. Together they form a unique fingerprint.
Keyphrases
Neuroscience
Pharmacology, Toxicology and Pharmaceutical Science